The Mammalian Tachykinins and Their Receptors: Structure-Activity Relationship of the Mammalian Tachykinins

  • Sadao Kimura
  • Katsutoshi Goto
  • Yuka Shigematsu
  • Yoshiki Sugita
  • Ichiro Kanazawa
Part of the Biochemical Endocrinology book series (BIOEND)


The tachykinins are a family of naturally occuring bioactive peptides, which share the common C-terminal amino acid sequence, Phe-X-Gly-Leu-Met-NH2 (Fig.1) and exhibit a wide spectrum of biological actions such as smooth muscle contraction, sialogogic action and hypotension (Ersparmer, 1981). Until recently, substance P (SP)(X=Phe) has been the only known tachykinin shown to be present in the mammalian tissues. The accumulating evidence suggest that SP is a neurotransmitter or neuromodulator in the central and peripheral nervous systems (Otsuka and Konishi, 1975; Pernow, 1983). We have recently determined the amino acid sequences of two additional and novel tachykinins (X=Va1), neurokinin A (NKA) and neurokinin B (NKB), which are remarkably similar to kassinin (Kimura et al., 1983). The identical peptides were independently reported and named differently; NKA as neuromedin L or substance K (Maggio et al., 1983; Minamino et al., 1984; Nawa et al., 1983) and NKB as neuromedin K (Kangawa et al., 1983). Pharmacologically, it was revealed that both neurokinins (NKs) possess the typical tachykinin activities and SP-E type ligand characteristics using peripheral tissues (Hunter and Maggio, 1984; Kimura et al., 1984; Nawa et al., 1984) and central nervous tissues (Buch et al., 1984; Mantyh et al., 1984; Quirion and Pilapil, 1984; Torrens et al., 1984). Electrophysiologically, it was found that both NKA and NKB have potent excitatory actions on neurons in the isolated spinal cord of neuborn rat (Matsuto et al., 1984). Moreover, we and others have shown using radioimmunoassay system that NKA and NKB are distributed unevenly in rat central nervous system (Kanazawa et al., 1984; Minamino et al., 1984). Especially, considerable amounts of NKs were found in the spinal cord and localized predominantly in the dorsal horn (Ogawa et al., 1985). Furthermore, the nucleotide sequences of two different SP precursors isolated from bovine striatum have been reported; one contains each copy of SP and NKA (substance K) while the other contains only substance P (Nawa et al., 1983). It was suggested that NKA (SK) may be coreleased with SP from the common precursor and serves as a second type of the endogenous tachykinin in mammalian tissue. These lines of evidence strongly suggested that NKs may act as neurotransmitters or neuromodulators like SP in mammalian central nervous system, especially, in the spinal cord.


Contractile Mechanism Tachykinin Receptor Biphasic Contraction Porcine Spinal Cord Tachykinin Peptide Family 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Buck, S.H., Burcher, E., Shults, C.W., Lovenberg, W., and O’Donohue, T.L., 1984, Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor, Science, 226:987.Google Scholar
  2. Ersparmer, V., 1981, The tachykinin peptide family, Trends neurosci., 4:267.CrossRefGoogle Scholar
  3. Hunter, J.C., and Maggio, J.E., 1984, Pharmacological characterization of a novel tachykinin isolated from mammalian spinal cord, Eur. J. Pharmacol. 97: 159.PubMedCrossRefGoogle Scholar
  4. Iversen, L.L., Hanley, M.R., Sandberg, B.E.B., Lee, C.M., Pinnock, R.D., and Watson, S.P., 1982, Substance P receptors in the nervous system and possible receptor subtypes, in “Substance P in the nervous system” R. Porter and M. O’Conner, eds., Pitman, London, pp186.Google Scholar
  5. Kanazawa, I., Ogawa, T., Kimura, S., and Munekata, E., 1984, Regionaldistribution of substance P, neurokinin a, and neurokinin β in rat central nervous system, Neurosci. Res., 2:111.PubMedCrossRefGoogle Scholar
  6. Kangawa, K., Minamino, K., Fukuda, A., and Matsuo, H., 1983, A novel tachykinin identified in porcine spinal cord, Biochem. Biophys. Res. Commun., 114:533.CrossRefGoogle Scholar
  7. Kimura, S., Goto, K., Ogawa, T., Sugita, Y., and Kanazawa, I., 1984, Pharmacological characterization of novel mammalian tachykinins, neurokinin a and neurokinin β, Neurosci. Res., 2:97.PubMedCrossRefGoogle Scholar
  8. Kimura, S., Ogawa, T., Goto, K., Shigematsu, Y., Yamashita, H., Sugita, Y., Munekata, E., and Kanazawa, I., 1985a, The mammalian tachykinin peptide family and their receptors, in “Natural products and Biological Activities”, Tokyo Univ. Press, Tokyo, in press.Google Scholar
  9. Kimura, S., Ogawa, T., Goto, K., Sugita, Y., Munekata, E., and Kanazawa, I., 1985b, Endogenous ligands for tachykinin receptors in mammals, in “Substance P —Metabolism and Biological Actions—”, Talor & Francis Ltd, London, in press.Google Scholar
  10. Kimura, S., Okada, M., Sugita, Y., Kanazawa, I., and Munekata, E., 1983, Novel neuropeptides, neurokinin a and β, isolated from porcine spinal cord, Proc. Japan Acad., 59B:101.CrossRefGoogle Scholar
  11. Lee, C.-M., Iversen, L.L., Hanley, M.R., and Sandberg, B.E.B., 1982, The possible existence of multiple receptors for substance P, Naunyn-Schmiedeberg’s Arch. Pharmacol., 318:281.Google Scholar
  12. Maggio, J.E., Sandberg, B.E.B., Bradley, C.V., Iversen, L.L., Santikarn, S., Williams, B.H., Hunter, J.C., and Hanley, M.R., 1983, Substance K: a novel tachykinin in mammalian spinal cord, in “Substance P —Dublin 1983”, P. Skarabanek, ed., Boole press, Dublin, pp20.Google Scholar
  13. Mantyh, P.W., Maggio, J.E., and Hunt, S.P., 1984, The autographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain, Eur. J. Pharmacol., 102:361.PubMedCrossRefGoogle Scholar
  14. Matsuto, T., Yanagisawa, M., Otsuka, M., Kanazawa, I., and Munekata, E., 1984, The exitatory action of the newly-discovered mammalian tachykinins, neurokinin a and neurokinin β, on neurons of the isolated spinal cord of the newborn rat, Neurosci. Res., 2:105.PubMedCrossRefGoogle Scholar
  15. Minamino, N., Matsuda, H., Kangawa, K., and Matsuo, H., 1984, Regional distribution of neuromedin K and neuromedin L in rat brain and spinal cord, Biochem. Biophys. Res. Commun., 124:731.CrossRefGoogle Scholar
  16. Nawa, H., Doteuchi, M., Igano, K., Inouye, K., and Nakanishi, S., 1984, Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile, Life Sci., 34:1153.PubMedCrossRefGoogle Scholar
  17. Nawa, H., Hirose, T., Takashima, H., Inayama, S., and Nakanishi, S., 1983, nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursors, Nature, 306:32.PubMedCrossRefGoogle Scholar
  18. Ogawa, T., Kanazawa, I., and Kimura, S., 1985, Regional distribution of substance P, neurokinin a and neurokinin β in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section on spinal transection, Brain Res., in press.Google Scholar
  19. Otsuka, M., and Konishi, S., 1975, Substance P and excitatory transmitter of primary sensory neurons, Cold Spring Harbor Symp. Quant. Biol., 40:135.CrossRefGoogle Scholar
  20. Pernow, B., 1983, Substance P, Pharmacol. Res., 35:135.Google Scholar
  21. Quirion, R., and Pilapil, C., 1984, Conparative potencies of substance P, substance K and neuromedin K on brain substance P receptors, Neuropeptides, 4:325.PubMedCrossRefGoogle Scholar
  22. Torrens, Y., Lavielle, S., Chassaing, G., Marguet, A., Glowinski, J., and Beaujouan, J.C., 1984, Neuromedin K, a tool to further distinguish two central tachykinin binding sites, Eur. J. Pharmacol., 102:381.PubMedCrossRefGoogle Scholar
  23. Watson, S.P., Sandberg, B.E.B., Hanley, M.R., and Iversen, L.L., 1983, Tissue selectivity of substance P alkyl esters: suggesting multiple receptors, Eur. J. Pharmacol., 87:77.PubMedCrossRefGoogle Scholar
  24. Watson, S.P., 1984, Are the proposed substance P receptor subtypes, substance P receptors? Life Sci., 25:797.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Sadao Kimura
    • 1
  • Katsutoshi Goto
    • 2
  • Yuka Shigematsu
    • 1
  • Yoshiki Sugita
    • 1
  • Ichiro Kanazawa
    • 3
  1. 1.Department of BiochemistryUniversity of TsukubaIbaraki 305Japan
  2. 2.Department of Pharmacology Institute of Basic Medical SciencesUniversity of TsukubaIbaraki 305Japan
  3. 3.Department of Neurology, Institute of Clinical MedicineUniversity of TsukubaIbaraki 305Japan

Personalised recommendations